Analyst Recommendations

Exane BNP Paribas analyst issues NEUTRAL recommendation for KDP on June 24, 2024 05:29AM ET. KDP was trading at $34.38 at issue of the analyst recommendation.The overall analyst...

June 24, 2024   KDP 1.02%

Exane BNP Paribas analyst issues NEUTRAL recommendation for PEP on June 24, 2024 05:27AM ET. PEP was trading at $167.28 at issue of the analyst recommendation.The overall analyst...

June 24, 2024   PEP 1.78%

Exane BNP Paribas analyst issues OUTPERFORM recommendation for PG on June 24, 2024 05:27AM ET. PG was trading at $168.26 at issue of the analyst recommendation.The overall analyst...

June 24, 2024   PG 1.13%

Barclays analyst issues EQUAL-WEIGHT recommendation for BKU on June 24, 2024 05:56AM ET. The previous analyst recommendation was Equal-Weight.BKU was trading at $28.03 at issue of the analyst...

June 24, 2024   BKU 2.75%

Barclays analyst issues EQUAL-WEIGHT recommendation for CADE on June 24, 2024 05:56AM ET. The previous analyst recommendation was Equal-Weight.CADE was trading at $27.53 at issue of the analyst...

June 24, 2024   CADE 2.60%

Barclays analyst issues EQUAL-WEIGHT recommendation for ASB on June 24, 2024 05:56AM ET. The previous analyst recommendation was Equal-Weight.ASB was trading at $20.29 at issue of the analyst...

June 24, 2024   ASB 3.94%

Exane BNP Paribas analyst issues UNDERPERFORM recommendation for MNST on June 24, 2024 05:29AM ET. MNST was trading at $49.09 at issue of the analyst recommendation.The overall analyst...

June 24, 2024   MNST 2.17%

Needham analyst issues BUY recommendation for PRAX on June 24, 2024 05:55AM ET. PRAX was trading at $41.7 at issue of the analyst recommendation.The overall analyst consensus :...

June 24, 2024   PRAX 0.53%

Cowen & Co. analyst issues BUY recommendation for PLNT on June 24, 2024 05:33AM ET. The previous analyst recommendation was Hold.PLNT was trading at $72.73 at issue of...

June 24, 2024   PLNT 2.22%

Barclays analyst issues OVERWEIGHT recommendation for RXO on June 24, 2024 05:53AM ET. The previous analyst recommendation was Overweight.RXO was trading at $20.21 at issue of the analyst...

June 24, 2024   RXO 3.67%